The AS Meniscal repair device is designed to allow orthopedic surgeons to perform “all-inside,” minimally invasive arthroscopic surgery to repair a torn meniscus in the knee using the “all-suture” method of fixation, according to the release.
“Covidien is setting new standards for consistency and reliability with this innovative, new design,” said Peter Marshall, director of R&D for Covidien, in the release. “The innovation seen in the design of the AS Meniscal repair device provides orthopedic surgeons with the confidence and security of an all-suture repair without the concern of rigid implant placement in soft tissue. Using feedback from our surgeon customers, we designed the AS Meniscal repair device to deliver optimal performance to address one of the fastest-growing orthopedic procedures performed today.”
Covidien has its U.S. headquarters in Mansfield, Mass.
Related Articles on New Technology:
FDA Enters Partnership to Help Increase Access to New Medical Devices
Given Imaging Applies for FDA Clearance for PillCam COLON 2
CareFusion Launches StartClean Preoperative Cleansing Program
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
